“…The subgroup for this disease mainly includes psoriasis vulgaris (also called plaque psoriasis), pustular psoriasis, psoriatic arthritis and erythrodermic psoriasis clinically [3,4], characterized by excessive growth of the epidermal layer of the skin, chronic inflammation in the dermis and parakeratosis [5]. Currently, the aetiology of psoriasis is not fully understood, but genetics, cell apoptosis and proliferation, immunity, inflammation and neurotransmitters are reported to be involved [6][7][8]. Although typical medications of psoriasis involve retinoid acids [9], methotrexate [10], cyclosporine [11], compound glycyrrhizin [12], few of them have targeting effects because of the complexity of psoriasis.…”